TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 2 | -4 | -4 | -21 | -35 | -10 |
| S | %wins | 33 | 33 | 67 | 33 | 100 | 100 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/03 17:30 | 12/8/03 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Clark David L | UT | O | VP,Opera | S | -37 | 30.50 | 26 | -1 | -26 | 3 | D | -21 | 10 | 15 | 1 | 14 | 18 | 3 | 1 | 3 | -1 | 10 | -14 | -35 | -45 |
9/15/03 18:56 | 9/10/03 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Clark David L | UT | O | VP,Opera | S.a | -359 | 30.91 | 21 | -12 | -78 | 3 | D | -7 | 67 | 107 | 20 | 27 | 23 | 16 | 3 | -3 | 3 | -12 | 2 | -17 | -31 |
9/11/03 11:33 | 9/10/03 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Clark David L | UT | O | VP,Opera | S | -359 | 30.91 | 21 | -12 | -78 | 3 | D | -8 | 60 | 98 | 14 | 26 | 27 | 13 | 14 | 4 | 4 | -10 | 1 | -12 | -30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |